lobbying_activities: 1665467

Individual lobbying activities reported in quarterly filings. Each row is one issue area for one client — includes the specific issues lobbied on, government entities contacted, and income/expense amounts.

Data license: Public Domain (U.S. Government data) · Data source: Federal Register API & Regulations.gov API

This data as json

id	filing_uuid	filing_type	registrant_name	registrant_id	client_name	filing_year	filing_period	issue_code	specific_issues	government_entities	income_amount	expense_amount	is_no_activity	is_termination	received_date
1665467	d034ef68-4be2-4307-8263-2c839bc0c462	Q1	EMPIRE CONSULTING GROUP	400703105	PHARMACEUTICAL RESEARCH AND MANUFACTURERS OF AMERICA	2015	first_quarter	PHA	Issues relating to the Medicare Prescription Drug Act; 340B Drug pricing program and drug pricing generally; patent reform proposals; S.320, Medical Innovation Act; funding for the National Institutes for Health; 2015 budget and Medicare Sustainable Growth Rate ("SGR").	HOUSE OF REPRESENTATIVES	40000		0	0	2015-04-16T22:35:36.883000-04:00